After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

Stuart Therapeutics completed a Phase 3 trial for ST-100, a treatment for dry eye disease, involving a randomized, ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...

Inherited eye disorders such as retinitis pigmentosa (RP) leave millions grappling with progressive vision loss. At the heart ...

A research team at the University of Iowa has identified the role of key genes and ultraviolet light in a common eye disease.

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The ...

Regenerative medicine is an exciting field with a promising future, capable of tackling inherent challenges seen with current therapies.

Cancers of the eye are exceedingly rare, and only a rare handful of cancer clinics in the nation are equipped to deal with ...

More than 3 million people in the U.S. are estimated to be living with glaucoma. By 2030, that number is expected to increase ...

Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

It was a tumor, he said — specifically, retinoblastoma, a cancer in her right eye that the Cleveland Clinic explains happens when cells multiply ... while she undergoes treatment, which includes ...